Ketamine
16.95 JOD
Please allow 2 – 5 weeks for delivery of this item
Description
The emergence of ketamine–previously known as a combat anesthetic and club drug–as a treatment for depression.Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years–in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug–that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.
Additional information
Weight | 0.1589 kg |
---|---|
Dimensions | 1.3716 × 12.7 × 17.78 cm |
by | |
format | |
Language | |
Pages | 208 |
publisher | |
Year Published | 2021-2-16 |
Imprint | |
Publication City/Country | USA |
ISBN 10 | 0262542242 |
About The Author | Bita Moghaddam is a leading researcher in the field of neuropsychopharmacology. She is Ruth Matarazzo Professor of Behavioral Neuroscience at Oregon Health and Science University in Portland. |
Table Of Content | Series Foreword ix Preface xi 1 The Molecule Ketamine 1 2 Uses of Ketamine 17 3 Neuroscience of Ketamine 31 4 Ketamine as an Antidepressant 65 5 How Does Ketamine Produce Antidepressant Effects? 101 6 Safety Concerns with Ketamine and Esketamine 121 7 Where Do We Go from Here? 141 Acknowledgments 155 Glossary 157 Notes 161 Further Reading 177 Index 179 |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.